# Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults

> **NCT02921659** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Colorado, Boulder** · enrollment: 30 (actual)

## Conditions studied

- Aging

## Interventions

- **DIETARY_SUPPLEMENT:** Niagen™
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02921659
- **Lead sponsor:** University of Colorado, Boulder
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-12-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02921659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02921659, "Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02921659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*